期刊文献+

血浆置换治疗中毒性表皮坏死松解症1例 被引量:1

A case report of plasma exchange for toxic epidermal necrolysis
下载PDF
导出
摘要 目的探讨中毒性表皮坏死松解症(TEN)病因、临床表现、预后和治疗方法。方法2016年8月山东大学齐鲁医院收治的1例41岁男性TEN病人,立即停用致敏药物,采用支持治疗和包括皮质激素、静脉注射免疫球蛋白、环孢素A、环磷酰胺、肿瘤坏死因子拮抗剂以及治疗性血浆置换等药物治疗。结果病人治愈出院,1年后随访,病人皮损部位恢复正常。结论TEN是一种严重的药物不良反应,其病理生理机制仍然不清楚,该病病情严重,病死率较高,提高对该病的早期诊断及鉴别诊断水平就显得尤为重要。TEN的治疗强调综合性治疗,对免疫反应的调节、对创面的护理、对全身状况的支持等都具有至关重要的作用。 Objective To explore the etiology,clinical manifestations,prognosis and treatment of toxic epidermal necrolysis(TEN).Methods In August 2016,A 41-year-old male patient with TEN admitted to Qilu hospital of shandong university immediately stopped using allergenic drugs and adopted supportive treatment including corticosteroids,intravenous immunoglobulin,cyclosporine A,cyclophosphamide,tumor necrosis factor antagonist and therapeutic plasma exchange.Results The patient was cured and discharged.After1 year of follow-up,the patient’s skin lesions returned to normal.Conclusion TEN is a serious adverse drug reaction,and its pathophysiological mechanism remains unclear.The disease is serious and the mortality rate is high.It is especially important to improve the early diagnosis and differential diagnosis of the disease.The treatment of TEN emphasizes comprehensive treatment,which plays a crucial role in the regulation of immune response,the care of wounds,and support for general condition.
作者 曹丽 CAO Li(Nursing Department,Qilu Hospital,Shandong University,Jinan,Shandong 250012,China)
出处 《安徽医药》 CAS 2019年第7期1434-1436,I0004,共4页 Anhui Medical and Pharmaceutical Journal
关键词 中毒性表皮坏死松解症 血浆置换 治疗 Toxic epidermal necrolysis Plasmapheresis Treatment
  • 相关文献

参考文献19

二级参考文献112

  • 1朱晓泉.中毒性表皮坏死松解症患者的护理体会[J].现代护理,2001,7(9):8-8. 被引量:2
  • 2陈艳明,何秀敏.头孢克洛致小儿皮肤关节型过敏性紫癜[J].药物不良反应杂志,2005,7(2):129-130. 被引量:4
  • 3石平荣,李凯,段逸群,周小勇.药物超敏反应综合征发病机制及治疗的研究进展[J].国际皮肤性病学杂志,2006,32(2):117-120. 被引量:48
  • 4万媛,雷翠云,万清清.1例老年重症药物疹患者合并败血症的护理[J].中华护理杂志,2007,42(1):47-48. 被引量:18
  • 5朱学骏,顾有守,沈丽玉.实用皮肤病性病治疗学[M].3版.北京:北京大学医学出版社.2007:329.
  • 6Roujeau JC, Kelly JP. Severe adverse cutaneous reactions to drugs[J]. New Engl J Med, 1994, 331: 1272-1285.
  • 7OplatekA, Brown K, Sen S, et al. Long-term follow-up of patients treated for toxic epidermal necrolysis[J]. J Burn Care Res, 2006, 27(1): 26-33.
  • 8Bastuji-Garin S, Fouchard N, Bertoechi M, et al. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis[J]. J Invest Dermatol, 2000, 115(2): 149-153.
  • 9Guegan S, Basruji-Garin S, Poszenpezynska-Guigne E, et al. Performance of the SCORTEN during the first five days of hospitalization to predict the prognosis of epidermal necrolysis[J]. J Invest Dermatol, 2006, 126(2): 272-276.
  • 10Bastuji-Garin S, Rzany B, Stern RS, et al. Clinical classification of cases of toxic epidermal necrolysis,Stevens-Johnson syndrome and erythema multiforme[J]. Arch Dermatol, 1993, 129(1): 92-96.

共引文献39

同被引文献6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部